Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potential

CCL22 is a macrophage-derived immunosuppressive chemokine that recruits regulatory T cells through the CCL22:CCR4 axis, playing an important role in homeostatic and inflammatory responses. A CCL22-overexpressing human induced pluripotent stem cell line (CNNDi001-A-2) was generated by lentiviral tran...

Full description

Bibliographic Details
Main Authors: Duan Jinliang, Bai Fang, Zhu Xiaofeng, He Xiaoshun, Hu Anbin
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S187350612300288X
_version_ 1797319498488872960
author Duan Jinliang
Bai Fang
Zhu Xiaofeng
He Xiaoshun
Hu Anbin
author_facet Duan Jinliang
Bai Fang
Zhu Xiaofeng
He Xiaoshun
Hu Anbin
author_sort Duan Jinliang
collection DOAJ
description CCL22 is a macrophage-derived immunosuppressive chemokine that recruits regulatory T cells through the CCL22:CCR4 axis, playing an important role in homeostatic and inflammatory responses. A CCL22-overexpressing human induced pluripotent stem cell line (CNNDi001-A-2) was generated by lentiviral transduction to further study the function of CCL22. The cell line was confirmed to have normal proliferation and pluripotency and could be further differentiated into islet cells for cell replacement therapy in diabetes.
first_indexed 2024-03-08T04:07:45Z
format Article
id doaj.art-95d711c5d17b4a738d28f059771e6712
institution Directory Open Access Journal
issn 1873-5061
language English
last_indexed 2024-03-08T04:07:45Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj.art-95d711c5d17b4a738d28f059771e67122024-02-09T04:47:54ZengElsevierStem Cell Research1873-50612024-03-0175103302Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potentialDuan Jinliang0Bai Fang1Zhu Xiaofeng2He Xiaoshun3Hu Anbin4Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong,China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Guangdong Provincial International Cooperation Base of Science and Technology(Organ Transplantation), Guangzhou, Guangdong, ChinaOrgan Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong,China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Guangdong Provincial International Cooperation Base of Science and Technology(Organ Transplantation), Guangzhou, Guangdong, ChinaOrgan Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong,China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Guangdong Provincial International Cooperation Base of Science and Technology(Organ Transplantation), Guangzhou, Guangdong, ChinaOrgan Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong,China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Guangdong Provincial International Cooperation Base of Science and Technology(Organ Transplantation), Guangzhou, Guangdong, ChinaOrgan Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong,China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Guangdong Provincial International Cooperation Base of Science and Technology(Organ Transplantation), Guangzhou, Guangdong, China; Corresponding author.CCL22 is a macrophage-derived immunosuppressive chemokine that recruits regulatory T cells through the CCL22:CCR4 axis, playing an important role in homeostatic and inflammatory responses. A CCL22-overexpressing human induced pluripotent stem cell line (CNNDi001-A-2) was generated by lentiviral transduction to further study the function of CCL22. The cell line was confirmed to have normal proliferation and pluripotency and could be further differentiated into islet cells for cell replacement therapy in diabetes.http://www.sciencedirect.com/science/article/pii/S187350612300288X
spellingShingle Duan Jinliang
Bai Fang
Zhu Xiaofeng
He Xiaoshun
Hu Anbin
Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potential
Stem Cell Research
title Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potential
title_full Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potential
title_fullStr Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potential
title_full_unstemmed Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potential
title_short Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potential
title_sort generation of a human induced pluripotent stem cell line overexpressing ccl22 with islet cells differentiation potential
url http://www.sciencedirect.com/science/article/pii/S187350612300288X
work_keys_str_mv AT duanjinliang generationofahumaninducedpluripotentstemcelllineoverexpressingccl22withisletcellsdifferentiationpotential
AT baifang generationofahumaninducedpluripotentstemcelllineoverexpressingccl22withisletcellsdifferentiationpotential
AT zhuxiaofeng generationofahumaninducedpluripotentstemcelllineoverexpressingccl22withisletcellsdifferentiationpotential
AT hexiaoshun generationofahumaninducedpluripotentstemcelllineoverexpressingccl22withisletcellsdifferentiationpotential
AT huanbin generationofahumaninducedpluripotentstemcelllineoverexpressingccl22withisletcellsdifferentiationpotential